An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs
Authors
Keywords
-
Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume -, Issue -, Pages 105454
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.neubiorev.2023.105454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second-generation antipsychotics and seizures – a systematic review and meta-analysis of serious adverse events in randomized controlled trials
- (2023) Leonie Reichelt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
- (2023) Carla Carnovale et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Atypical antipsychotic-induced mania: A systematic review and meta-analysis
- (2023) Beatriz Côrte-Real et al. JOURNAL OF AFFECTIVE DISORDERS
- Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis
- (2022) Anna Ceraso et al. SCHIZOPHRENIA BULLETIN
- Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
- (2022) Christoph U. Correll et al. World Psychiatry
- The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials
- (2022) Giovanni Croatto et al. MOLECULAR PSYCHIATRY
- Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials
- (2022) Che-Yin Lin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies
- (2021) Yinzhao Liu et al. Therapeutic Advances in Psychopharmacology
- Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis
- (2021) Giovanni Ostuzzi et al. AMERICAN JOURNAL OF PSYCHIATRY
- Urinary side effects of psychotropic drugs: A systematic review and metanalysis
- (2021) Margherita Trinchieri et al. NEUROUROLOGY AND URODYNAMICS
- Long-term metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trials
- (2020) Francesco Rotella et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Assessment of publication bias and outcome reporting bias in systematic reviews of health services and delivery research: A meta-epidemiological study
- (2020) Abimbola A. Ayorinde et al. PLoS One
- The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis
- (2020) Z. Wang et al. PSYCHOLOGICAL MEDICINE
- Medications as a Risk Factor for Fragility Hip Fractures: A Systematic Review and Meta-analysis
- (2020) Sharri J. Mortensen et al. CALCIFIED TISSUE INTERNATIONAL
- Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects
- (2020) Marco Solmi et al. World Psychiatry
- Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013–2018
- (2020) Jeff A. Dennis et al. BMC Psychiatry
- Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
- (2019) Koen Demyttenaere et al. CNS DRUGS
- Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies
- (2019) D. Papola et al. ACTA PSYCHIATRICA SCANDINAVICA
- Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis
- (2019) Sanja Zivkovic et al. BMC Psychiatry
- Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
- (2019) Stephen J. Kaar et al. NEUROPHARMACOLOGY
- Antipsychotic drug exposure and risk of fracture
- (2018) Davide Papola et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Meta-analysis and review of dopamine agonists in acute episodes of mood disorder: Efficacy and safety
- (2018) Bruno Romeo et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Does antipsychotic drug use increase the risk of long term mortality? A systematic review and meta-analysis of observational studies
- (2018) Chunsong Yang et al. Oncotarget
- Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
- (2018) Eric Achtyes et al. BMC Psychiatry
- The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials
- (2018) Hui Ma et al. JOURNAL OF ALZHEIMERS DISEASE
- Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
- (2018) Lawrence Blonde et al. ADVANCES IN THERAPY
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials
- (2016) Kim S. J. Lao et al. CNS DRUGS
- Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
- (2016) Peng Li et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- The heterogeneity statistic I2 can be biased in small meta-analyses
- (2015) Paul T von Hippel BMC Medical Research Methodology
- Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies
- (2015) Michela Nosè et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach
- (2015) Christoffer Polcwiartek et al. PSYCHOPHARMACOLOGY
- A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
- (2015) Tessa Kennedy-Martin et al. Trials
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Paliperidone Palmitate for Schizophrenia
- (2012) A. M. Nussbaum et al. SCHIZOPHRENIA BULLETIN
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now